ESR1 and breast cancer: The benefits of evaluating biomarker expression under direct microscopic visualization in the context of histologically interpretable tissue sections, rather than “grind and bind” methods such as those used in most biochemical experiments including most genomics and proteomics methods, is perhaps best illustrated by the history of estrogen receptor (ER) quantitation in breast cancer.